ClinVar Miner

Submissions for variant NM_000530.8(MPZ):c.584+2T>G (rs879254054)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000235519 SCV000293316 pathogenic not provided 2015-11-19 criteria provided, single submitter clinical testing The c.584+2 T>G splice site variant in the MPZ gene has been previously reported, using alternative nomeclature of c.614+2 T>G, in association with CMT1B, and RT-PCR studies on dermal skin biopsies confirmed that c.584+2 T>G is associated with abnormal splicing (Sabet et al., 2006). This pathogenic variant destroys the canonical splice donor site in intron 4, and is expected to cause abnormal gene splicing. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.
Inherited Neuropathy Consortium RCV000790116 SCV000929506 uncertain significance Charcot-Marie-Tooth disease no assertion criteria provided literature only
OMIM RCV000015261 SCV000035520 pathogenic Charcot-Marie-Tooth disease, demyelinating, type 1b 2006-10-10 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.